Fig. 1From: Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjectsBaseline characteristics of treatment groups. Number of cases in each treatment (total: n = 109). Baseline breakdown of statins for each treatment group was shownBack to article page